Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
Clinical trial NCT02572492 · UNKNOWN
Trial details
- NCT number
- NCT02572492
- Sponsor
- Henrik Gregersen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-04-23
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.